Temasek Holdings (Private) LTD Beam Therapeutics Inc. Transaction History

Temasek Holdings (Private) LTD

$20 Billion
Q4 2024

A detailed history of Temasek Holdings (Private) LTD transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Temasek Holdings (Private) LTD holds 1,812,972 shares of BEAM stock, worth $46.6 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

1,812,972

Previous 1,812,972 -0.0%

Holding current value

$46.6 Million

Previous $44.4 Million 1.22%

% of portfolio

0.22%

Previous 0.18%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$22.57 - $33.14 $40.9 Million - $60.1 Million	1,812,972 New	1,812,972 $44.4 Million
Q1 2024 May 15, 2024	SELL	$23.46 - $45.07 $29.6 Million - $56.9 Million	-1,263,145 Reduced 41.06%	1,812,972 $59.9 Million
Q4 2023 Feb 14, 2024	SELL	$17.69 - $30.76 $22 Million - $38.2 Million	-1,241,672 Reduced 28.76%	3,076,117 $83.7 Million
Q2 2023 Aug 14, 2023	BUY	$29.32 - $35.99 $6.55 Million - $8.04 Million	223,277 Added 5.45%	4,317,789 $138 Million
Q1 2023 May 15, 2023	BUY	$30.15 - $48.79 $36.7 Million - $59.3 Million	1,216,215 Added 42.25%	4,094,512 $125 Million
Q4 2022 May 15, 2023	BUY	$36.73 - $51.6 $441,825 - $620,696	12,029 Added 0.42%	2,878,297 $113 Million
Q4 2022 Feb 14, 2023	BUY	$36.73 - $51.6 $441,825 - $620,696	12,029 Added 0.42%	2,878,297 $113 Million
Q3 2022 May 15, 2023	SELL	$39.79 - $70.31 $43.5 Million - $76.8 Million	-1,092,944 Reduced 27.61%	2,866,268 $137 Million
Q3 2022 Apr 05, 2023	SELL	$39.79 - $70.31 $478,633 - $845,758	-12,029 Reduced 0.42%	2,866,268 $137 Million
Q3 2022 Nov 14, 2022	SELL	$39.79 - $70.31 $43.5 Million - $76.8 Million	-1,092,944 Reduced 27.61%	2,866,268 $137 Million
Q1 2022 May 15, 2023	BUY	$53.73 - $82.16 $58.1 Million - $88.8 Million	1,080,915 Added 37.55%	3,959,212 $227 Million
Q1 2022 May 16, 2022	BUY	$53.73 - $82.16 $27 Million - $41.2 Million	501,827 Added 14.51%	3,959,212 $227 Million
Q2 2021 Aug 16, 2021	BUY	$64.12 - $128.71 $3.29 Million - $6.61 Million	51,372 Added 1.51%	3,457,385 $445 Million
Q1 2021 May 17, 2021	BUY	$71.28 - $120.75 $3.66 Million - $6.2 Million	51,372 Added 1.53%	3,406,013 $273 Million
Q1 2020 May 15, 2020	BUY	$13.31 - $29.2 $44.7 Million - $98 Million	3,354,641 New	3,354,641 $60.4 Million

Others Institutions Holding BEAM

# of Institutions

253

Shares Held

78.6M

Call Options Held

304K

Put Options Held

142K

View Full List

About Beam Therapeutics Inc.

Ticker BEAM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,354,600
Market Cap $1.81B
Description
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...

More about BEAM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Temasek Holdings (Private) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Temasek Holdings (Private) LTD with notifications on news.

Account

Temasek Holdings (Private) LTD Beam Therapeutics Inc. Transaction History